CEAPRO INC.
TSX VENTURE : CZO

CEAPRO INC.

January 18, 2007 09:00 ET

Ceapro Inc. appoints Chief Financial Officer

EDMONTON, Jan. 18 - NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW.

Ceapro Inc. (TSX VENTURE:CZO) ("Ceapro" or the "Corporation")
today announced the appointment of Branko Jankovic as Chief
Financial Officer. Mr Jankovic joined Ceapro in October 2006 as Controller,
was instrumental in developing a (3-year) Strategic Business Plan, and quickly
adapted to the dynamic environment at the Company.

Mr. Jankovic was a business consultant to public, private, and
governmental clients for nine years. He had previously worked for eight years
in the construction industry and three years for a real estate development
company. He graduated from Lakehead University in 1983 with an HBComm and was
awarded the Dean Braun medal for top standing. He obtained the Chartered
Accountant designation in 1985 from the Institute of Chartered Accountants in
Alberta.

"We are pleased that Mr. Jankovic has accepted the important
responsibilities of Chief Financial Officer at Ceapro," said Dr. Mark Redmond,
the Corporation's President and CEO. "Given the current regulatory environment
and the challenges faced by public issuers, we require wide investment market
experience and a senior financial perspective. Mr. Jankovic brings both
characteristics to his new role."

"I am very enthusiastic about my role within the organization and
optimistic about Ceapro's corporate development and strategies," said
Mr. Jankovic. "I look forward to playing a part in further strengthening
Ceapro's financial position, and assuring its long term expansion and growth."

About Ceapro Inc.

Ceapro Inc. is a Canadian growth stage biotechnology company. Ceapro's
core technology is the extraction of functional, active ingredients from
plants and other renewable resources. We add further value to our extracts by
manufacturing medical and therapeutic products, and by supporting the use of
our extracts in products for human and animal health. We have also introduced
health and wellness services employing our CeaProve® diagnostic technology.
Our most recent initiative is the creation of Ceapro BioEnergy Inc. (CBE), a
wholly-owned subsidiary to utilize Ceapro's proprietary technology for the
production of ethanol and value-added products. Ceapro shares trade on the
Canadian TSX Venture Exchange under the symbol CZO. To learn more about
Ceapro, visit our website at www.ceapro.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of this news release.

This release may contain forward-looking statements. Various factors
could cause actual results to differ materially from those projected in
forward-looking statements. Although the Company believes that the
forward-looking statements contained herein are reasonable, it can give no
assurance that the Company's expectations are correct. All forward-looking
statements are expressly qualified in their entirety by this cautionary
statement.

Contact Information

  • Dr. Mark Redmond, President and CEO, Ceapro
    Inc., Telephone (Edmonton): (780) 421-4555; Nicole Blanchard, B.Sc., B.Comm.,
    Managing Partner, Sun International Communications, Telephone (Montreal):
    (450) 627-6600